Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 2 4Phase EARLY_PHASE1 2Phase 1 2Phase 4 1Phase 3 1

Status

Completed 4Terminated 1Recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 3

Conditions

Renal Insufficiency, Chronic 1Prostatic Neoplasms 1Kidney Neoplasms 1Carcinoma, Renal Cell 1

Interventions

Cyclophosphamide 739Cisplatin 687Gemcitabine 641Bevacizumab 615Carboplatin 604Paclitaxel 600Docetaxel 565Radiotherapy 536Fluorouracil 405Oxaliplatin 387Rituximab 369Doxorubicin 360Capecitabine 342Filgrastim 333Etoposide 328Dexamethasone 312Irinotecan 309pembrolizumab 279Leucovorin 274Cetuximab 267Cytarabine 242Erlotinib Hydrochloride 231Prednisone 227Nivolumab 227Trastuzumab 225Bortezomib 221Vincristine 220Methotrexate 207Pemetrexed 199fludarabine phosphate 195

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Completed × perflutren × Clear all
NCT02967458 2025-04-30

Detection of High Grade Prostate Cancer With Subharmonic Ultrasound Imaging, A Pilot Study

Thomas Jefferson University

Phase 2 Completed
55 enrolled 8 charts
Genitourinary

Prostatic Neoplasms

NCT03907657 2024-05-21

CEUS-VHL

UNC Lineberger Comprehensive Cancer Center

Phase 2 Completed
15 enrolled 7 charts

Renal Insufficiency, Chronic

NCT04021238 2023-11-13

Contrast-Enhanced Ultrasound for Kidney Cancer Subtyping and Staging

UNC Lineberger Comprehensive Cancer Center

Phase 2 Completed
25 enrolled 28 charts
Genitourinary

Kidney Neoplasms

NCT01062178 2016-03-08

Efficacy of Ultrasound Contrast Agent to Assess Renal Masses

University Health Network, Toronto

Phase 2 Completed
167 enrolled
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡